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ABSTRACT 
 
Background: Inherited retinal diseases (IRDs) are a group of genetic disorders with high degrees of clinical, genetic 
and allelic heterogeneity. IRDs generally show progressive retinal cell death resulting in gradual vision loss. IRDs 
constitute a broad spectrum of disorders including retinitis pigmentosa and Leber congenital amaurosis. In this 
study, we performed genotyping studies to identify the underlying mutations in three Iranian families. Methods: 
Having employed homozygosity mapping and Sanger sequencing, we identified the underlying mutations in the 
crumbs homologue 1 gene. The CRB1 protein is a part of a macromolecular complex with a vital role in retinal cell 
polarity, morphogenesis, and maintenance. Results: We identified a novel homozygous variant (c.1053_1061del; 
p.Gly352_Cys354del) in one family, a combination of a novel (c.2086T>C; p.Cys696Arg) and a known variant 
(c.2234C>T, p.Thr745Met) in another family and a homozygous novel variant (c.3090T>A; p.Asn1030Lys) in a third 
family. Conclusion: This study shows that mutations in CRB1 are relatively common in Iranian non-syndromic IRD 
patients. DOI: 10.18869/acadpub.ibj.21.5.294  
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INTRODUCTION 
 
nherited retinal diseases (IRDs) are a group of 
genetic disorders characterized by progressive 
degeneration of retinal cells and vision loss
[1]
. 
These disorders affect approximately 1 in 4,000 
people, i.e. more than 2.4 million people are affected 
worldwide
[2]
. IRDs are well-known for their genetic 
and clinical heterogeneity as mutations in 240 genes 
are shown to be involved (https://sph.uth.edu/retnet/) 
and affected people represent different phenotypes in 
terms of onset, progression, and severity of the 
disease
[3]
.  IRDs can be subdivided into non-syndromic 
forms such as retinitis pigmentosa (RP) and Leber 
congenital amaurosis (LCA), as well as syndromic 
forms such as Bardet-Biedl and Usher syndromes
[1]
. 
LCA is the most severe and congenital form of IRDs; 
the prevalence of which varies from 1:30,000 to 
1:81,000. Clinical characteristics of the disease are 
severe visual impairment at birth, most of the time a 
non-detectable electroretinogram, sluggish or absent 
pupillary response, and oculodigital reflexes. Some 
patients also have hyperopia and nystagmus
[4]
. 
Generally, RP is less severe compared to LCA and 
has a later age of onset
[4]
. The earliest characteristic of 
the disease is night blindness, followed by peripheral 
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vision loss and tunnel vision, and some patients will 
become legally blind
[5]
. Prevalence of the disease is 
estimated to be approximately 1 in 4,000 worldwide
[6]
. 
Bone spicule pigmentation, attenuation of retinal 
vessels, a waxy pallor appearance of optic disc, and 
various levels of retinal atrophy can be seen in the 
fundus of RP patients. Electroretinography of RP 
patients show severe reduction in a and b waves
[6]
.  RP 
can be inherited as an autosomal dominant (adRP, 
about 30%-40% of cases), autosomal recessive (arRP, 
50%-60%, with sporadic cases responsible for about 
45% of all RP patients), or X-linked (xlRP, 5%-20%). 
Digenic inheritance has also been reported rarely. 
A recessive mode of inheritance is more prevalent in 
countries like Iran due to the high prevalence of 
consanguineous marriages. Homozygosity mapping 
has been proven to be very successful in the 
identification of causal genes in such cases. This 
method involves detection of the disease locus in DNA 
of affected children of a consanguineous family by the 
fact that affected siblings carry identical homozygous 
chromosomal segments in which the causal variant is 
suspected. Homozygous regions can be identified using 
large sets of single nucleotide polymorphism (SNP) 
markers
[7,8]
. The advent of dense SNP-based 
genotyping microarrays has made homozygosity 
mapping faster and more effective
[3]
. Homozygosity 
mapping is particularly useful for mutation detection in 
genetically heterogeneous conditions, like IRDs, since 
it can minimize the number of genes that need to be 
sequenced to find the causative mutation
[9]
.   
Despite the genetic heterogeneous nature of the 
disease, some of these genes are mutated more often in 
certain groups of IRD. One of these frequently mutated 
genes is crumbs homologue 1 (CRB1; 
OMIM#604210), which is a human homologue of a 
Drosophila melanogaster gene that encodes crumbs 
protein. Mutations in CRB1 are responsible for 10-15% 
of LCA cases and 4% of all cases of RP
[10,11]
, and 
cumulatively they cause visual impairment in an 
estimated 80,000 patients worldwide
[12]
. The majority 
of the mutations in this gene are in exon 9 (41% of the 
cases) and exon 7 (27% of all cases)
[13,14]
.  
Previous studies have shown that up to 6.5% of arRP  
patients have a mutation in CRB1, which is located at 
chromosome 1q31.3 and consists of 12 exons
[14]
. This 
gene is expressed in the brain and retina, and an 
alternative splicing at 3' end of the gene leads to the 
synthesis of a longer protein with 1406 amino acids 
and a shorter one with 1376 amino acids
[15]
. Both of 
these proteins have 19 epidermal growth factor (EGF)-
like domains, three laminin A globular-like domains 
and a signal peptide. In addition, the longer isoform 
has a single transmembrane and a small 37-amino-acid 
intracellular domain
[16]
. CRB1 is located in the 
subapical region of the photoreceptor, and its 
intracellular domain creates complexes with 
intracellular proteins, which altogether are called the 
crumbs protein complex
[17]
. These protein complexes 
take part in the organization of macromolecular 
complexes crucial for cell polarity, morphogenesis, and 
maintenance of retina
[16]
. Various studies have shown 
that mutations in CRB1 can cause different retinal 
dystrophies ranging from LCA to RP
[13,14]
.  
Upon funduscopic analysis of patients with IRDs 
caused by mutations in CRB1 gene, namely LCA type 
8 (LCA8; 613835) and RP type 12 (RP12; 600105), 
additional specific features may be found, including 
preservation of para-arteriolar retinal pigment 
epithelium (PPRPE) and coats-like vasculopathy. 
PPRPE is the preservation of RPE cells adjacent to and 
under retinal arterioles, while all other RPE cells of 
retina have degenerated. Coats-like vasculopathy 
increases the permeability of retinal vessels resulting in 
exudative retinal detachment and often is accompanied 
by massive deposits of subretinal lipids
[12]
.  
Very little is known about the genetic landscape of 
IRDs in the Iranian population. In this study, we 
searched for genetic defects in Iranian IRD families 
using homozygosity mapping and Sanger sequencing 
and identified three families with CRB1 variants.     
 
 
MATERIALS AND METHODS 
 
Subjects 
In total, 86 autosomal recessive, four autosomal 
dominant, and three X-linked pedigrees with a 
minimum of two members showing the signs and 
symptoms of retinal degeneration from various 
geographical parts of Iran (Iranian IRD cohort) were 
included in this study. A written informed consent 
adhering to the tenets of the Declaration of Helsinki 
was obtained from the probands of each family. 
Peripheral blood samples of all pedigree members were 
collected and mixed with EDTA anticoagulant (Merck 
KGaA, Darmstadt, Germany). A phenol-chloroform 
method was used to extract DNAs from peripheral 
leukocytes
[18]
, and DNAs were stored at 4
o
C until 
further analysis.  
Two affected individuals from 10 selected pedigrees 
were tested by affymetrix CytoScan HD™ whole 
genome SNPs array. Homozygous regions were 
determined by an online tool, i.e. Homozygosity 
Mapper (http://www.homozygositymapper.org)
[19]
. 
Homozygous regions of more than 2 Mb were ranked 
according to their size. Previous studies have indicated 
that the largest homozygous segments are more likely 
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to carry the causative mutation
[20]
. Genes associated 
with retinal disease phenotypes residing in these 
regions were prioritized for Sanger sequencing. Sanger 
sequencing was also used for segregation analysis. 
 
Clinical characterization 
Diagnoses of the patients were established by a  
trained ophthalmologist using Electroretinography 
(Metrovision MonPack3, 4 rue des Platanes, 59840 
Pérenchies, France), evaluation of visual acuity, and 
Funduscopy (Topcon TRC-50EX Retinal Camera, 75-
1. Hasunuma-cho, Itabashi-ku, Tokyo, Japan). 
 
Genotyping 
Primers used for PCR reactions (Table 1) were 
designed by Primer3 software. PCR products were 
purified with exonuclease and thermosensitive alkaline 
phosphatase (Thermo Fisher scientific
TM
, Waltham, 
Massachusetts, USA) and analyzed by Sanger 
sequencing using BigDye® Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems
TM
, Foster city, 
California, USA) ABI 3730XL platform (Applied 
Biosystems
TM
). To assess the pathogenicity of the 
missense variants identified in this study, various 
software were used, including SIFT 
(http://sift.jcvi.org), PolyPhen-2 (http://genetics.bwh. 
harvard.edu/pph2), and Combined Annotation 
Dependent Depletion (CADD) score assessment 
(http://cadd.gs.washington.edu/score).  The   frequency 
 
of these variants was also determined using Exome 
Aggregation Consortium (ExAC), Cambridge, MA, 
USA (http://exac.broadinstitute.org; accessed on 
2015/11/26).  
 
 
RESULTS 
 
Employing homozygosity mapping, one family 
(W13-0007) out of the 10 families analyzed by whole 
genome SNP array, showed linkage to the 
chromosomal region containing CRB1. This family is a 
consanguineous family from Mazandaran province in 
the north of Iran, with four affected and one unaffected 
siblings. The parents are first cousins (Fig. 1A). A total 
of 63 Mb of the genome was shared between two 
affected members of the family, who were analyzed by 
Affymetrix CytoScan HD array (W13-0007; IV:3 and 
W13-0007; IV:4). The largest homozygous region was 
about 42 Mb and contained three IRD-associated 
genes: CRB1, RD3 (retinal degeneration 3; OMIM# 
180040), and USH2A (Usher syndrome type 2A; 
OMIM# 608400). Bearing in mind the contribution of 
the disease genes towards IRD phenotypes, CRB1 was 
prioritized for sequencing. Sanger sequencing of CRB1 
identified a novel 9-bp in-frame homozygous deletion 
(Fig. 2A) in exon 5 (c.1053_1061del; p.Gly352_ 
Cys354del), which was segregating in the family (Fig. 
1A).  
 
        Table 1. List of primers and sequences 
 
Exon #  Forward primer (5’-3’) Reverse primer (5’- 3’) 
1 
 
CGCTCCTCTCTGAGACAGAC TTTTATAGAACATGCAACATTATCC 
2.1 
 
AATGAGTTTGGTTGAGGCAG ATATCCAGCAGGGCAGATG 
2.2 
 
CAGTGGGACAATCTGTGAAAC AATGTCACCTCTGCTTCTGC 
3 
 
GCTAAATTATGAACACTTTGCTAAAAC GGTAAAATAGTTCATGGTCAGGG 
4 
 
CATGGGTCTTGGGTTGATAG TTCATTTCATTTGCTATAAGCG 
5 
 
AACCTCCTTTTAGGCAAATG GGTTAAAGCCATGGTCTGC 
6.1 
 
GAGCTATTCATGCACTTCTGC GCCTCTGCAAATATTACCTCC 
6.2 
 
GAAGCTGGAGCTGCTAAGTG TTTGCTGTTTCTGCTCTGC 
7.1 
 
TCCATCCCTTCTGTCTTTTG TCCTAGGTTTTGTGAAGACTGA 
7.2 
 
TGGTGGGTCAGTAACATCATC GCAATGCTGACTCCAAACTC 
8 
 
CAGATATGTGGTTTCACCGTC TCTGTGTTTGCTCTTGGAAC 
9.1 
 
AAAAGCAACTAGCACAGTATGTAAC AACTGCAAACAGCCAGTGAC 
9.2 
 
TGTGGGAGACAGAGCTATTGA CTTGAGGAGAGAGCTTTCCAA 
10 
 
CTTTTCTTGAATGAGATGAACAAG GAACTTTGAGTAATCCCATCATTC 
11 
 
GCTGTTCCAGAGAGATAAGGC CTCAACAACTGGCTCGTCAT 
12 
 
TTCCTGAGTAGTTCCATTGTCC CCCAGTTGCAGATTAACATTG 
List of primer used for Sanger sequencing of CRB1 gene. Multiple overlapping primers were used to amplify and sequence exons 2, 
6, 7, and 9. 
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Fig. 1. Pedigrees and segregation of CRB1 variants of the Iranian families participated in this study. (A) Family W13-0007; (B) 
family W13-1504; (C) family W13-1493. Affected individuals are indicated with filled symbols, whereas unaffected relatives are 
shown by open circles or rectangles. Symbols with a slash depict deceased individuals. Arrows indicate probands. +, wild type allele; 
M1, c.1053_1061del (p.Gly352_Cys354del), M2, c.2234C>T (p.Thr745Met); M3, c.2086T>C (p.Cys696Arg); M4, c.3090T>A 
(p.Asn1030Lys). Roman letters represent number of generations. 
 
 
 
 
 
 
Fig. 2. Sequence chromatograms of the CRB1 variants. (A) The novel homozygous mutation (c.1053_1061del; p.Gly352_Cys354 
del) in IV:4 of family W13-0007; (B) the recurrent mutation (c.2234C>T; p.Thr745Met) in V:6 of family W13-1504; (C) the novel 
mutation (c.2086T>C; p.Cys696Arg) in V:6 of family W13-1504; (D) the novel mutation (c.3090T>A; p.Asn1030Lys) in IV:7 of 
family W13-1493. Letters highlighted in yellow indicate the altered nucleic acid. 
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Since the majority (68%) of CRB1 mutations reside 
in exons 7 and 9, these exons in our Iranian IRD panel 
were sequenced. In this way, we identified two 
mutations, a previously identified heterozygous variant 
(c.2234C>T; p.Thr745Met) https://databases.lovd.nl/ 
shared/variants/ CRB1/unique
[22]
 in exon 7 (Fig. 2B) 
and a novel homozygous variation (c.3090T>A; 
p.Asn1030Lys) in exon 9 (Fig. 2D), in probands of 
families W13-1504 (Fig. 1B) and W13-1493 (Fig. 1C), 
respectively. Subsequently, all other exons of CRB1 
were sequenced in the proband of family W13-1504, 
and a second likely pathogenic variant (c.2086T>C; 
p.Cys696Arg) was found in exon 6 (Fig. 2C). Family 
W13-1504 was from Eastern Azerbaijan, and family 
W13-1493 was from the Zanjan province. The 
identified variants are segregated with the disease in 
the respective families. 
Evaluation of family histories showed that the first 
symptom of RD appeared in all affected members of 
all three families in their childhood. The speed of 
disease progression varies among different families and 
even among affected siblings of one family. Upon 
funduscopic examination, typical features of RP were 
observed in all three families and included peripheral 
bone spicule pigmentation, retinal blood vessels 
attenuation, pallor optic disk, and maculopathy (Fig. 
3). In addition, all members of family W13-1504 had 
nystagmus and bilateral cataract. Clinical 
characteristics of the patients are summarized in Table 
2. 
All of the missense variants found in this study were 
analyzed by predictive tools. The result of these 
analyses, generally, support the pathogeniecity of the 
variants (Table3). 
 
 
 
Fig. 3. Fundus photographs of the selected normal and affected individuals. (A) W13-0007, individuals III-2 (normal) and IV:4 
(affected); (B) W13-1504 individuals V-2 (normal) and V:6 (affected); (C) W13-1493 individuals IV-6 (normal) and IV:7 (affected) 
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  Table 2. Clinical characteristics of the affected pedigree members participating in this study 
 
Patient 
Current 
age (year) 
Gender 
Age of 
onset (year) 
Visual acuity Fundus appearance 
W13-0007: IV-3 34 F 6 Hand motion 
Peripheral bone spicules, attenuated retinal blood 
vessels, macular degeneration 
      
W13-0007: IV-4 32 F 8 
OD: 5/10 
OS: 5.5/10 
Peripheral bone spicules, attenuated retinal blood 
vessels, macular degeneration 
      
W13-1504: V-3 49 F 3 LP+ 
Peripheral bone spicules, attenuated retinal blood 
vessels, macular coloboma, nystagmus, cataract 
      
W13-1504: V-6 39 F 3 LP+ 
Peripheral bone spicules, attenuated retinal blood 
vessels, macular coloboma, nystagmus, cataract 
      
W13-1493: IV-3 60 M 4 TB Not applicable because of severe cataract 
      
W13-1493: IV-7 43 M 4 LP+ 
Peripheral bone spicules, attenuated retinal blood 
vessels, macular degeneration 
 
F, female; M, male; TB, total blindness; LP+, light perception; OD, oculus dexter, right eye; OS, oculus sinister, left eye. 
 
 
DISCUSSION 
 
We identified the underlying mutations in the CRB1 
gene in three Iranian retinal degeneration families. 
Although consanguineous marriages are common in 
Iranian society
[23]
, which makes the Iranian gene pool a 
valuable asset for genetic studies, very little is known 
about genetics of retinal degeneration in the Iranian 
population. To our knowledge, only two studies have 
been reported on genetic causes of Iranian IRD 
patients
[24,25]
. 
Interestingly, a combination of a known mutation in 
exon 7 and a novel mutation in exon 6 of CRB1 was 
found in affected members of the consanguineous 
family W13-1504. This result is not unprecedented as 
compound heterozygous variants that have previously 
been reported in other consanguineous families with 
recessive diseases, inside and outside Iran
[26,27]
 and 
even in CRB1 in non-Iranian RP patients
[28]
. 
Two of three novel mutations found in this study 
involve cysteine residues. Cysteine is crucial in 
disulfide bonds formation and subsequently in three 
dimensional structure of CRB1
[13,14]
. The mutation 
found in family W13-0007 deletes a segment of 3 
amino acids (p.Gly352_Cys354 del) from CRB1. This 
segment is a part of the 9
th
 EGF-like domain in CRB1. 
Cysteine 354 forms a disulfide bond with another 
cysteine at position 343. Patients of family W13-1504 
have compound heterozygous mutations. One of the 
mutations (c.2234C>T, p.Thr745Met) has previously 
been reported and is among the most prevalent  
CRB1 variants (https://databases.lovd.nl/shared/ 
variants/CRB1/unique)
[22]
. However, the other one 
(c.2086T>C, p.Cys696Arg) is a novel variant in exon 
6, which leads to the replacement of a cysteine residue 
at  position  696  by  an  arginine.  Cysteine  at position 
696 is located in 12
th
 EGF-like domain and makes a 
disulfide  bond  with  cysteine  681.  None of these two 
 
 
Table 3. In-silico analysis of the missense mutations identified in this study 
 
Family 
ID 
 DNA variant; 
Chromosomal 
position  
Protein change Grantham PhyloP SIFT PolyPhen-2 
 
CADD 
score 
ExAC 
Minor allele 
frequency 
Ref. 
W13-
1504 
c.2086T>C; 
Chr1-197391044T>C 
p.Cys696Arg 180 4.73 Del PD 24 Absent 
This 
study 
          
W13-
1504 
c.2234C>T; 
Chr1-197396689C>T 
p.Thr745Met 81 4.16 Del PD 23.6 T=0.000083 [22] 
         
 
W13-
1493 
 c.3090T>A; 
Chr1-197404083T>A  
p.Asn1030Lys 94 -0.36 Del PD 18.17 Absent 
This 
study 
 
SIFT, sorting intolerant from tolerant; PolyPhen-2, polymorphism phenotyping; CADD, combined annotation dependent depletion; 
ExAC, Exome Aggregation Consortium; Del, deleterious; PD, probably damaging 
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Fig. 4. Conservation of cysteine residues in epidermal growth factor (EGF) domains of human CRB1 (UniProtKB - P82279). The 
mutated cysteine residues are present in all 19 EGF-like domains 
 
 
changes are among highly conserved cysteine residues 
of CRB1 protein reported previously
[13]
. However, 
when we aligned all 19 EGF-like domains of human 
CRB1 protein, it became evident that both of the 
mutated cysteine residues are conserved inside these 
domains (Fig. 4). Comparing the full-length protein 
sequence of CRB1 among seven species also showed 
that cysteine residues at positions 354 and 696 were 
conserved during the evolution of these species (Fig. 
5). Conservation of these cysteine residues inside 
different EGF-like domains and among CRB1 protein 
of different species demonstrates their importance in 
structure and/or function of human CRB1 protein.  
The third novel homozygous variant (c.3090T>A; 
p.Asn1030Lys) found in family W13-1493 is 
considered causal as SIFT and PolyPhen2 predicted it 
to be deleterious and disease causing, it is segregating 
in the family, and also the variant is absent in all 
databases containing sequence variants in control 
individuals.   
Considering that IRDs are genetically heterogeneous 
diseases, and none of the genes involved have a high 
frequency, results of this study show that mutations in 
CRB1 are relatively common in Iranian IRD patients. 
Identification of pathogenic events at the molecular 
level can help clinicians and health professionals 
improve and expedite the diagnosis of the disease and 
provide patients and their families with a more accurate 
genetic counseling. Increasing the knowledge about 
molecular mechanisms involved in IRD pathogenesis 
may also lead to the development of new treatment 
options for affected individuals in the future.  
 
 
 
Fig. 5. Conservation of mutated residues identified in this study in full-length CRB1 from different species. Amino acids are depicted 
with one letter code. Black boxes show the conserved amino acid residues in different species. 
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